Table Of Content

AFFUERNCATL IOVF E DISORDERS ELSS SEVIER Journal of Affective Disorders 79 (2004) 307—309 www.elsevier.com/locate/jad Author index Allen, M.T., see Straneva-Meuse, P.A. (79) 51 Charles, M., see Matthey, S. (79) 113 Amos, T., see Douglas, J. (79) 263 Chawky, N., see Lalovic, A. (79) 25 Appleby, L., see Douglas, J. (79) 263 Cisse, M., see Karege, F. (79) 187 Aro, H., see Hamalainen, J. (79) 105 Clemmensen, L., see Martiny, K. (79) 253 Cohen, L.S., see Harlow, B.L. (79) 167 Baethge, C., Gruschka, P., Berghéfer, A., Bauer, M., Miiller- Cooper, J., see Douglas, J. (79) 263 Oerlinghausen, B., Bschor, T. and Smolka, M.N. Cramer, D.W., see Harlow, B.L. (79) 167 Csabi, G., seeényi, T. (79) 259 Prophylaxis of schizoaffective disorder with lithium or carba- Cuijpers, P., de Graaf, R. and van Dorsselaer, S. mazepine: outcome after long-term follow-up (79) 43 Minor depression: risk profiles, functional disability, health care Ballesteros, J. and Callado, L.F. Effectiveness of pindolol plus serotonin uptake inhibitors in use and risk of developing major depression (79) 71 depression: a meta-analysis of early and late outcomes from D’Argenio, A., see Troisi, A. (79) 269 randomised controlled trials (79) 137 De Dios, C., see Ezquiaga, E. (79) 63 Barkow, K., Heun, R., Wittchen, H.-U., Bedirhan Ustiin, T., De Graaf, R., see Cuijpers, P. (79) 71 Gansicke, M. and Maier, W. DeGuzman, R., see Lalovic, A. (79) 25 Mixed anxiety—depression in a | year follow-up study: shift to Dell’Osso, L., see Benedetti, A. (79) 273 other diagnoses or remission? (79) 235 Demonfaucon, F., see Millet, B. (79) 241 Barnett, B., see Matthey, S. (79) 113 Dikeos, D., see Blairy, S. (79) 97 Barrot, I., see Millet, B. (79) 241 Douglas, J., Cooper, J., Amos, T., Webb, R., Guthrie, E. and Bauer, M., see Baethge, C. (79) 43 Appleby, L. Bech, P., see Martiny, K. (79) 253 “‘Near-fatal” deliberate self-harm: characteristics, prevention Bedirhan Ustiin, T., see Barkow, K. (79) 235 and implications for the prevention of suicide (79) 263 Benedetti, A., Lattanzi, L., Pini, S., Musetti, L., Dell’Osso, L. and Dyer, E.J., see Khawaja, N.G. (79) 217 Cassano, G.B. Oxcarbazepine as add-on treatment in patients with bipolar Erickson, M., see Price, J.S. (79) 1 manic, mixed or depressive episode (79) 273 Ezquiaga, E., Garcia-Lopez, A., de Dios, C., Leiva, A., Bravo, M. Berghéfer, A., see Baethge, C. (79) 43 and Montejo, J. Blairy, S., Linotte, S., Souery, D., Papadimitriou, G.N., Dikeos, D., Clinical and psychosocial factors associated with the outcome of Lerer, B., Kaneva, R., Milanova, V., Serretti, A., Macciardi, F. unipolar major depression: a one year prospective study (79) 63 and Mendlewicz, J. Social adjustment and self-esteem of bipolar patients: a Fava, M., see Perlis, R.H. (79) 291 multicentric study (79) 97 Ferrando, L., see Montes, J.M. (79) 229 Bourdel, M.C., see Millet, B. (79) 241 Franke, L., see Miiller-Oerlinghausen, B. (79) 13 Boyce, P., see Wilhelm, K. (79) 33 Bravo, M., see Ezquiaga, E. (79) 63 Gallarda, T., see Millet, B. (79) 241 Brownhill, S., see Wilhelm, K. (79) 33 Gansicke, M., see Barkow, K. (79) 235 Bschor, T., see Baethge, C. (79) 43 Garcia-Lopez, A., see Ezquiaga, E. (79) 63 Bullock, T., see Sampson, E. (79) 223 Gardner Jr., R., see Price, J.S. (79) 1 Gilbert, J., see Gilbert, P. (79) 149 Callado, L.F., see Ballesteros, J. (79) 137 Gilbert, P., Gilbert, J. and Irons, C. Carpenter, L.L., Heninger, G.R., Malison, R.T., Tyrka, A.R. and Life events, entrapments and arrested anger in depression (79) Price, L.H. 149 Cerebrospinal fluid interleukin (IL)-6 in unipolar major Girdler, S.S., see Straneva-Meuse, P.A. (79) 51 depression (79) 285 Goering, P., see Gratzer, D. (79) 209 Cassano, G.B., see Benedetti, A. (79) 273 Golding, M., see Straneva-Meuse, P.A. (79) 51 doi: 10.1016/S0165-0327(04)00066-7 308 Author index Gratzer, D., Levitan, R.D., Sheldon, T., Toneatto, T., Rector, N.A. Kutcher, S., Kusumakar, V., LeBlanc, J., Santor, D., Lagace, D. and and Goering, P. Morehouse, R. Lifetime rates of alcoholism in adults with anxiety, depression, The characteristics of asymptomatic female adolescents at high or co-morbid depression/anxiety: a community survey of risk for depression: the baseline assessment from a prospective Ontario (79) 209 8-year study (79) 177 Greenfield, S.F., see Weiss, R.D. (79) 279 Griffin, M.L., see Weiss, R.D. (79) 279 Lachausse, C., see Karege, F. (79) 187 Gruschka, P., see Baethge, C. (79) 43 Lagace, D., see Kutcher, S. (79) 177 Guthrie, E., see Douglas, J. (79) 263 Lalovic, A., Sequeira, A., DeGuzman, R., Chawky, N., Lesage, A., Seguin, M. and Turecki, G. Hamialainen, J., Isometsa, E., Laukkala, T., Kaprio, J., Poikolainen, Investigation of completed suicide and genes involved in K., Heikkinen, M., Lindeman, S. and Aro, H. cholesterol metabolism (79) 25 Use of health services for major depressive episode in Finland Lam, D., Wright, K. and Smith, N. (79) 105 Dysfunctional assumptions in bipolar disorder (79) 193 Hantouche, E.G., see Millet, B. (79) 241 Lattanzi, L., see Benedetti, A. (79) 273 Harlow, B.L., Cohen, L.S., Otto, M.W., Spiegelman, D. and Laukkala, T., see Hamalainen, J. (79) 105 Cramer, D.W. LeBlanc, J., see Kutcher, S. (79) 177 Early life menstrual characteristics and pregnancy experiences Leiva, A., see Ezquiaga, E. (79) 63 among women with and without major depression: the Harvard Lerer, B., see Blairy, S. (79) 97 study of moods and cycles (79) 167 Lesage, A., see Lalovic, A. (79) 25 Hedges, D.W., see Preston, G.A. (79) 297 Levitan, R.D., see Gratzer, D. (79) 209 Heikkinen, M., see Hamialadinen, J. (79) 105 Light, K.C., see Straneva-Meuse, P.A. (79) 51 Heimberg, R.G., see Stein, M.B. (79) 161 Lindeman, S., see Hamalainen, J. (79) 105 Heninger, G.R., see Carpenter, L.L. (79) 285 Linotte, S., see Blairy, S. (79) 97 Heun, R., see Barkow, K. (79) 235 Loo, H., see Millet, B. (79) 241 Howie, P., see Matthey, S. (79) 113 Lunde, M., see Martiny, K. (79) 253 lalongo, N., McCreary, B.K., Pearson, J.L., Koenig, A.L., Schmidt, Macciardi, F., see Blairy, S. (79) 97 N.B., Poduska, J. and Kellam, S.G. Maier, W., see Barkow, K. (79) 235 Major depressive disorder in a population of urban, African- Malison, R.T., see Carpenter, L.L. (79) 285 American young adults: prevalence, correlates, comorbidity and Marchant, B.K., see Preston, G.A. (79) 297 unmet mental health service need (79) 127 Martiny, K., Simonsen, C., Lunde, M., Clemmensen, L. and Irons, C., see Gilbert, P. (79) 149 Bech, P. Isometsa, E., see Hamalainen, J. (79) 105 Decreasing TSH levels in patients with Seasonal Affective Disorder (SAD) responding to | week of bright light therapy Jacobson, L.M., see Weiss, R.D. (79) 279 (79) 253 Jeges, S., see Tenyi, T. (79) 259 Matthey, S., Kavanagh, D.J., Howie, P., Barnett, B. and Charles, M. Prevention of postnatal distress or depression: an evaluation of Kalaria, R.N., see Thomas, A.J. (79) 81 an intervention at preparation for parenthood classes (79) 113 Kaneva, R., see Blairy, S. (79) 97 McCreary, B.K., see lalongo, N. (79) 127 Kaprio, J., see Hamalainen, J. (79) 105 Mendlewicz, J., see Blairy, S. (79) 97 Karege, F., Schwald, M., Papadimitriou, P., Lachausse, C. and Milanova, V., see Blairy, S. (79) 97 Cisse, M. Millet, B., Kochman, F., Gallarda, T., Krebs, M.O., Demonfaucon, The cAMP-dependent protein kinase A and _ brain-derived F., Barrot, I., Bourdel, M.C., Olié, J.P., Loo, H. and neurotrophic factor expression in lymphoblast cells of bipolar Hantouche, E.G. affective disorder (79) 187 Phenomenological and comorbid features associated in obses- Kavanagh, J.J., see Matthey, S. (79) 113 sive—compulsive disorder: influence of age of onset (79) 241 Kellam, S.G., see lalongo, N. (79) 127 Montejo, J., see Ezquiaga, E. (79) 63 Khawaja, N.G. and Dyer, E.J. Montes, J.M., Ferrando, L. and Saiz-Ruiz, J. Anxious Thoughts and Tendencies Scale: An investigation of Remission in major depression with two antidepressant factor structure and the psychometric properties on the basis of mechanisms: results from a naturalistic study (79) 229 an Australian sample (79) 217 Morehouse, R., see Kutcher, S. (79) 177 Kochman, F., see Millet, B. (79) 241 Mukherjee, S., see Sampson, E. (79) 223 Koenig, A.L., see Ialongo, N. (79) 127 Mullan, N., see Sampson, E. (79) 223 Kolodziej, M., see Weiss, R.D. (79) 279 Miiller-Oerlinghausen, B., Roggenbach, J. and Franke, L. Krebs, M.O., see Millet, B. (79) 241 Serotonergic platelet markers of suicidal behavior—do they Kusumakar, V., see Kutcher, S. (79) 177 really exist? (79) 13 Author index Miiller-Oerlinghausen, B., see Baethge, C. (79) 43 Smoller, J.W., see Perlis, R.H. (79) 291 Musetti, L., see Benedetti, A. (79) 273 Souery, D., see Blairy, S. (79) 97 Spiegelman, D., see Harlow, B.L. (79) 167 Najavits, L.M., see Weiss, R.D. (79) 279 Stein, M.B. and Heimberg, R.G. Nierenberg, A.A., see Perlis, R.H. (79) 291 Well-being and life satisfaction in generalized anxiety disorder: comparison to major depressive disorder in a community sample O’Brien, J.T., see Thomas, A.J. (79) 81 (79) 161 Olié, J.P., see Millet, B. (79) 241 Straneva-Meuse, P.A., Light, K.C., Allen, M.T., Golding, M. and Otto, M.W., see Harlow, B.L. (79) 167 Girdler, S.S. Bupropion and paroxetine differentially influence cardiovascu- Papadimitriou, G.N., see Blairy, S. (79) 97 lar and neuroendocrine responses to stress in depressed patients Papadimitriou, P., see Karege, F. (79) 187 (79) 51 Pearson, J.L., see lalongo, N. (79) 127 Strong, R.E., see Preston, G.A. (79) 297 Perlis, R.H., Smoller, J.W., Fava, M., Rosenbaum, J.F., Nierenberg, A.A. and Sachs, G.S. Tavares, A., see Volpe, F.M. (79) 201 The prevalence and clinical correlates of anger attacks during Tenyi, T., Trixler, M., Csabi, G. and Jeges, S. depressive episodes in bipolar disorder (79) 291 Minor physical anomalies in non-familial unipolar recurrent Pini, S., see Benedetti, A. (79) 273 major depression (79) 259 Poduska, J., see lalongo, N. (79) 127 Thomas, A.J., Kalaria, R.N. and O’Brien, J.T. Poikolainen, K., see Hamaldinen, J. (79) 105 Depression and vascular disease: what is the relationship? (79) Preston, G.A., Marchant, B.K., Reimherr, F.W., Strong, R.E. and 81 Hedges, D.W. Toneatto, T., see Gratzer, D. (79) 209 Borderline personality disorder in patients with bipolar disorder Trixler, M., see Tényi, T. (79) 259 and response to lamotrigine (79) 297 Troisi, A. and D’Argenio, A. Price, L.H., see Carpenter, L.L. (79) 285 The relationship between anger and depression in a clinical Price, J.S., Gardner Jr., R. and Erickson, M. sample of young men: the role of insecure attachment (79) 269 Can depression, anxiety and somatization be understood as Turecki, G., see Lalovic, A. (79) 25 appeasement displays? (79) | Tyrka, A.R., see Carpenter, L.L. (79) 285 Rector, N.A., see Gratzer, D. (79) 209 Ukoumunne, O.C., see Sampson, E. (79) 223 Reimherr, F.W., see Preston, G.A. (79) 297 Roggenbach, J., see Miiller-Oerlinghausen, B. (79) 13 Van Dorsselaer, S., see Cuijpers, P. (79) 71 Rosenbaum, J.F., see Perlis, R.H. (79) 291 Volpe, F.M. and Tavares, A. Manic patients receiving ECT in a Brazilian sample (79) 201 Sachs, G.S., see Yildiz, A. (79) 247 Sachs, G.S., see Perlis, R.H. (79) 291 Saiz-Ruiz, J., see Montes, J.M. (79) 229 Webb, R., see Douglas, J. (79) 263 Sampson, E., Mukherjee, S., Ukoumunne, O.C., Mullan, N. and Weiss, R.D., Kolodziej, M., Griffin, M.L., Najavits, L.M., Jacobson, Bullock, T. L.M. and Greenfield, S.F. History of deliberate self-harm and its association with mood Substance use and perceived symptom improvement among fluctuation (79) 223 patients with bipolar disorder and substance dependence (79) Santor, D., see Kutcher, S. (79) 177 279 Schmidt, N.B., see Ialongo, N. (79) 127 Wilhelm, K., Boyce, P. and Brownhill, S. Schwald, M., see Karege, F. (79) 187 The relationship between interpersonal sensitivity, anxiety Seguin, M., see Lalovic, A. (79) 25 disorders and major depression (79) 33 Sequeira, A., see Lalovic, A. (79) 25 Wittchen, H.-U., see Barkow, K. (79) 235 Serretti, A., see Blairy, S. (79) 97 Wright, K., see Lam, D. (79) 193 Sheldon, T., see Gratzer, D. (79) 209 Simonsen, C., see Martiny, K. (79) 253 Yildiz, A. and Sachs, G.S. Smith, N., see Lam, D. (79) 193 Characteristics of rapid cycling bipolar-I patients in a bipolar Smolka, M.N., see Baethge, C. (79) 43 speciality clinic (79) 247 AFJFOUERNCATL IVOF E DISORDERS Journal of Affective Disorders 79 (2004) 311—314 www.elsevier.com/locate/jad Subject index Adolescent; Depression; Female; Risk factors 79, 177 Attachment; Depression; Anger 79, 269 Affective disorder; Depression; Evolution; Communication; Anxi- Atypical depression; Seasonal Affective Disorder; Thyroid-stim- ety disorder; Somatoform disorder; Chronic fatigue syndrome; ulating hormone; TSH 79, 253 Appeasement; Submission 79, | BDNF; Bipolar disorder; cAMP-dependent PKA; Lymphoblast 79, African-Americans; Major depression; Young adults 79, 127 187 Age of onset; Obsessive—compulsive disorder; Early onset; Late Behavioural activation system theory; Dysfunctional attitudes; onset; Depression; Tics 79, 241 Bipolar disorder 79, 193 Age of onset; Rapid cycling; Gender 79, 247 Biological markers; Neurodevelopment; Minor physical anomalies; Unipolar recurrent major depression 79, 259 Alcohol abuse; Major depression; Anxiety disorders; Co-morbidity; Epidemiology; Community sample 79, 209 Bipolar; Lamotrigine; Borderline personality disorder 79, 297 Anger; Depression; Entrapment; Escape; Life events 79, 149 Bipolar depression; Oxcarbazepine; Bipolar disorder; Mood- stabilizers; Mania; Carbamazepine 79, 273 Anger; Depression; Attachment 79, 269 Bipolar disorder; Self-esteem; Social-adjustment 79, 97 Anger attacks; Bipolar disorder; Depression; Phenomenology 79, 291 Bipolar disorder; cAMP-dependent PKA; BDNF; Lymphoblast 79, 187 Antenatal classes; Postnatal depression; Preparation; Fathers 79, 113 Bipolar disorder; Dysfunctional attitudes; Behavioural activation system theory 79, 193 Antidepressant; Depression; Remission; Serotonin; Noradrenaline 79, 229 Bipolar disorder; Oxcarbazepine; Mood-stabilizers; Mania; Bipo- lar depression; Carbamazepine 79, 273 Anxiety; Major depression; Generalized anxiety disoder; Quality of life; Well-being; Health; 79, 161 Bipolar disorder; Substance abuse; Self-medication; Substance dependence; Dual diagnosis 79, 279 Anxiety; Cognition; Anxious thoughts; Anxious tendencies 79, 217 Bipolar disorder; Depression; Anger attacks; Phenomenology 79, Anxiety disorder; Depression; Evolution; Communication; Affec- 291 tive disorder; Somatoform disorder; Chronic fatigue syndrome; Appeasement; Submission 79, | Borderline personality disorder; Lamotrigine; Bipolar 79, 297 Anxiety disorders; Interpersonal sensitivity; Major depression 79, Bupropion; Paroxetine; Depression; Heart rate variability; Stress 33 79, 51 Anxiety disorders; Major depression; Alcohol abuse; Co-morbid- cAMP-dependent PKA; Bipolar disorder; BDNF; Lymphoblast 79, ity; Epidemiology; Community sample 79, 209 187 Anxious tendencies; Anxiety; Cognition; Anxious thoughts 79, 217 Carbamazepine; Oxcarbazepine; Bipolar disorder; Mood-stabilizers; Mania; Bipolar depression 79, 273 Anxious thoughts; Anxiety; Cognition; Anxious tendencies 79, 217 Cerebrospinal fluid; Interleukin-6; Cytokines; Depression; Psy- choneuroimmunology; Mood disorder 79, 285 Appeasement; Depression; Evolution; Communication; Affective disorder; Anxiety disorder; Somatoform disorder; Chronic fatigue Cholesterol; Completed suicide; Suicidal behavior; Genetic syndrome; Submission 79, | variation 79, 25 doi: 10.1016/S0165-0327(04)00067-9 312 Subject index Chronic fatigue syndrome; Depression; Evolution; Communica- Early onset; Obsessive—compulsive disorder; Age of onset; Late tion; Affective disorder; Anxiety disorder; Somatoform disorder; onset; Depression; Tics 79, 241 Appeasement; Submission 79, | Effectiveness; Depression; Meta-analysis; Outcome; Pindolol; Cognition; Anxiety; Anxious thoughts; Anxious tendencies 79, 217 SSRI 79, 137 Communication; Depression; Evolution; Affective disorder; Anxi- Electroconvulsive therapy (ECT); Mania; Inpatients; Treatment ety disorder; Somatoform disorder; Chronic fatigue syndrome; decision 79, 201 Appeasement; Submission 79, | Entrapment; Depression; Escape; Anger; Life events 79, 149 Community sample; Major depression; Anxiety disorders; Alcohol Epidemiology; Depression; Vascular disease; Neuroimaging; Neu- abuse; Co-morbidity; Epidemiology 79, 209 ropathology 79, 81 Co-morbidity; Major depression; Anxiety disorders; Alcohol Epidemiology; Major depression; Anxiety disorders; Alcohol abuse; Epidemiology; Community sample 79, 209 abuse; Co-morbidity; Community sample 79, 209 Completed suicide; Suicidal behavior; Genetic variation; Choles- Epidemiology; Mixed anxiety—depression; Stability; Validity 79, terol 79, 25 235 Cytokines; Cerebrospinal fluid; Interleukin-6; Depression; Psycho- Escape; Depression; Entrapment; Anger; Life events 79, 149 neuroimmunology; Mood disorder 79, 285 Evolution; Depression; Communication; Affective disorder; Anxi- Deliberate self-harm; Suicidality; Depression 79, 223 ety disorder; Somatoform disorder; Chronic fatigue syndrome; Appeasement; Submission 79, | Deliberate self-harm; Serious suicide attempt; Depression; Suicide risk; Suicide prevention 79, 263 Fathers; Postnatal depression; Antenatal classes; Preparation 79, 113 Depression; Evolution; Communication; Affective disorder; Anxi- ety disorder; Somatoform disorder; Chronic fatigue syndrome; Female; Depression; Adolescent; Risk factors 79, 177 Appeasement; Submission 79, | Functional disability; Minor depression; Major depression; Heath Depression; Bupropion; Paroxetine; Heart rate variability; Stress care use; Prospective study 79, 71 79, 51 Gender; Rapid cycling; Age of onset 79, 247 Depression; Vascular disease; Epidemiology; Neuroimaging; Neu- Generalized anxiety disoder; Major depression; Anxiety; Quality ropathology 79, 81 of life; Well-being; Health; 79, 161 Depression; Effectiveness; Meta-analysis; Outcome; Pindolol; Genetic variation; Completed suicide; Suicidal behavior; Choles- SSRI 79, 137 terol 79, 25 Depression; Entrapment; Escape; Anger; Life events 79, 149 Health; Major depression; Generalized anxiety disoder; Anxiety; Depression; Female; Adolescent; Risk factors 79, 177 Quality of life; Well-being; 79, 161 Depression; Remission; Antidepressant; Serotonin; Noradrenaline Health services; Major depression; Use 79, 105 79, 229 Heath care use; Minor depression; Major depression; Functional Depression; Obsessive—compulsive disorder; Age of onset; Early disability; Prospective study 79, 71 onset; Late onset; Tics 79, 241 Heart rate variability; Bupropion; Paroxetine; Depression; Stress Depression; Deliberate self-harm; Suicidality 79, 223 79, 51 Depression; Deliberate self-harm; Serious suicide attempt; Suicide Inpatients; Mania; Electroconvulsive therapy (ECT); Treatment risk; Suicide prevention 79, 263 decision 79, 201 Depression; Anger; Attachment 79, 269 Interleukin-6; Cerebrospinal fluid; Cytokines; Depression; Psy- choneuroimmunology; Mood disorder 79, 285 Depression; Cerebrospinal fluid; Interleukin-6; Cytokines; Psycho- neuroimmunology; Mood disorder 79, 285 Interpersonal sensitivity; Anxiety disorders; Major depression 79, 33 Depression; Bipolar disorder; Anger attacks; Phenomenology 79, 291 Lamotrigine; Bipolar; Borderline personality disorder 79, 297 Dual diagnosis; Bipolar disorder; Substance abuse; Self-medica- Late onset; Obsessive—compulsive disorder; Age of onset; Early tion; Substance dependence 79, 279 onset; Depression; Tics 79, 241 Dysfunctional attitudes; Bipolar disorder; Behavioural activation Latency; Schizoaffective disorder; Prophylaxis; Predictors; Lithium system theory 79, 193 79, 43 Subject index 313 Life events; Depression; Entrapment; Escape; Anger 79, 149 Outcome; Major depression; Personality; Psychosocial variables 79, 63 Lithium; Schizoaffective disorder; Prophylaxis; Predictors; Latency 79, 43 Outcome; Depression; Effectiveness; Meta-analysis; Pindolol; SSRI 79, 137 Lymphoblast; Bipolar disorder; cAMP-dependent PKA; BDNF 79, 187 Oxcarbazepine; Bipolar disorder; Mood-stabilizers; Mania; Bipolar depression; Carbamazepine 79, 273 Major depression; Interpersonal sensitivity; Anxiety disorders 79, 33 Paroxetine; Bupropion; Depression; Heart rate variability; Stress Major depression; Personality; Psychosocial variables; Outcome 79, 51 79, 63 Personality; Major depression; Psychosocial variables; Outcome Major depression; Minor depression; Functional disability; Heath 79, 63 care use; Prospective study 79, 71 Phenomenology; Bipolar disorder; Depression; Anger attacks 79, Major depression; Health services; Use 79, 105 291 Pindolol; Depression; Effectiveness; Meta-analysis; Outcome; SSRI Major depression; African-Americans; Young adults 79, 127 79, 137 Major depression; Generalized anxiety disoder; Anxiety; Quality Postnatal depression; Antenatal classes; Preparation; Fathers 79, of life; Well-being; Health; 79, 161 113 Major depression; Menstruation; Pregnancy; Risk factors 79, 167 Predictors; Schizoaffective disorder; Prophylaxis; Latency; Lith- Major depression; Anxiety disorders; Alcohol abuse; Co-morbid- ium 79, 43 ity; Epidemiology; Community sample 79, 209 Pregnancy; Major depression; Menstruation; Risk factors 79, 167 Mania; Inpatients; Electroconvulsive therapy (ECT); Treatment Preparation; Postnatal depression; Antenatal classes; Fathers 79, decision 79, 201 113 Mania; Oxcarbazepine; Bipolar disorder; Mood-stabilizers; Bipolar Prophylaxis; Schizoaffective disorder; Predictors; Latency; Lithium depression; Carbamazepine 79, 273 79, 43 Menstruation; Major depression; Pregnancy; Risk factors 79, 167 Prospective study; Minor depression; Major depression; Functional Meta-analysis; Depression; Effectiveness; Outcome; Pindolol; disability; Heath care use 79, 71 SSRI 79, 137 Psychoneuroimmunology; Cerebrospinal fluid; Interleukin-6; Cy- Minor depression; Major depression; Functional disability; Heath tokines; Depression; Mood disorder 79, 285 care use; Prospective study 79, 71 Psychosocial variables; Major depression; Personality; Outcome Minor physical anomalies; Neurodevelopment; Unipolar recurrent 79, 63 major depression; Biological markers 79, 259 Quality of life; Major depression; Generalized anxiety disoder; Mixed anxiety—depression; Stability; Validity; Epidemiology 79, Anxiety; Well-being; Health; 79, 161 235 Rapid cycling; Age of onset; Gender 79, 247 Mood disorder; Cerebrospinal fluid; Interleukin-6; Cytokines; Remission; Depression; Antidepressant; Serotonin; Noradrenaline Depression; Psychoneuroimmunology 79, 285 79, 229 Mood-stabilizers; Oxcarbazepine; Bipolar disorder; Mania; Bipolar Risk factors; Major depression; Menstruation; Pregnancy 79, 167 depression; Carbamazepine 79, 273 Risk factors; Depression; Female; Adolescent 79, 177 Neurodevelopment; Minor physical anomalies; Unipolar recurrent major depression; Biological markers 79, 259 Schizoaffective disorder; Prophylaxis; Predictors; Latency; Lith- ium 79, 43 Neuroimaging; Depression; Vascular disease; Epidemiology; Neuropathology 79, 81 Seasonal Affective Disorder; Thyroid-stimulating hormone; TSH; Atypical depression 79, 253 Neuropathology; Depression; Vascular disease; Epidemiology; Neuroimaging 79, 81 Self-esteem; Bipolar disorder; Social-adjustment 79, 97 Noradrenaline; Depression; Remission; Antidepressant; Serotonin Self-medication; Bipolar disorder; Substance abuse; Substance 79, 229 dependence; Dual diagnosis 79, 279 Obsessive—compulsive disorder; Age of onset; Early onset; Late Serious suicide attempt; Deliberate self-harm; Depression; Suicide onset; Depression; Tics 79, 241 risk; Suicide prevention 79, 263 314 Subject index Serotonin; Depression; Remission; Antidepressant; Noradrenaline Suicide prevention; Deliberate self-harm; Serious suicide attempt; 79, 229 Depression; Suicide risk 79, 263 Social-adjustment; Bipolar disorder; Self-esteem 79, 97 Suicide risk; Deliberate self-harm; Serious suicide attempt; Depression; Suicide prevention 79, 263 Somatoform disorder; Depression; Evolution; Communication; Affective disorder; Anxiety disorder; Chronic fatigue syndrome; Thyroid-stimulating hormone; Seasonal Affective Disorder; TSH; Appeasement; Submission 79, | Atypical depression 79, 253 SSRI, Depression; Effectiveness; Meta-analysis; Outcome; Pindolol Tics; Obsessive—compulsive disorder; Age of onset; Early onset; 79, 137 Late onset; Depression 79, 241 Stability; Mixed anxiety—depression; Validity; Epidemiology 79, Treatment decision; Mania; Inpatients; Electroconvulsive therapy 235 (ECT) 79, 201 Stress; Bupropion; Paroxetine; Depression; Heart rate variability TSH; Seasonal Affective Disorder; Thyroid-stimulating hormone; 79, 51 Atypical depression 79, 253 Submission; Depression; Evolution; Communication; Affective Unipolar recurrent major depression; Neurodevelopment; Minor physical anomalies; Biological markers 79, 259 disorder; Anxiety disorder; Somatoform disorder; Chronic fatigue syndrome; Appeasement 79, ij Use; Major depression; Health services 79, 105 Substance abuse; Bipolar disorder; Self-medication; Substance Validity; Mixed anxiety—depression; Stability; Epidemiology 79, dependence; Dual diagnosis 79, 279 235 Substance dependence; Bipolar disorder; Substance abuse; Self- Vascular disease; Depression; Epidemiology; Neuroimaging; medication; Dual diagnosis 79, 279 Neuropathology 79, 81 Suicidal behavior; Completed suicide; Genetic variation; Choles- Well-being; Major depression; Generalized anxiety disoder; terol 79, 25 Anxiety; Quality of life; Health; 79, 161 Suicidality; Deliberate self-harm; Depression 79, 223 Young adults; Major depression; African-Americans 79, 127 Vol. 79 Contents